Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo

OBJECTIVES: Antitumour necrosis factor (TNF) therapy has revolutionised treatment of several chronic inflammatory diseases, including spondyloarthritis (SpA). However, TNF inhibitors (TNFi) are not effective in all patients and the biological basis for treatment failure remains unknown. We have anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Menegatti, Silvia, Guillemot, Vincent, Latis, Eleonora, Yahia-Cherbal, Hanane, Mittermüller, Daniela, Rouilly, Vincent, Mascia, Elena, Rosine, Nicolas, Koturan, Surya, Millot, Gael A, Leloup, Claire, Duffy, Darragh, Gleizes, Aude, Hacein-Bey-Abina, Salima, Sellam, Jérémie, Berenbaum, Francis, Miceli-Richard, Corinne, Dougados, Maxime, Bianchi, Elisabetta, Rogge, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958106/
https://www.ncbi.nlm.nih.gov/pubmed/33268443
http://dx.doi.org/10.1136/annrheumdis-2020-218304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958106/
https://www.ncbi.nlm.nih.gov/pubmed/33268443
http://dx.doi.org/10.1136/annrheumdis-2020-218304

Ejemplares similares